Understanding of latent tuberculosis, its treatment and treatment side effects in immigrant and refugee patients
Version 3 2024-06-19, 07:22Version 3 2024-06-19, 07:22
Version 2 2024-06-13, 15:03Version 2 2024-06-13, 15:03
Version 1 2022-10-31, 02:19Version 1 2022-10-31, 02:19
journal contribution
posted on 2024-06-19, 07:22authored byK Butcher, BA Biggs, K Leder, C Lemoh, D O'Brien, C Marshall
Abstract
Background
Isoniazid treatment of latent tuberculosis infection (LTBI) is commonly prescribed in refugees and immigrants. We aimed to assess understanding of information provided about LTBI, its treatment and potential side effects.
Methods
A questionnaire was administered in clinics at a tertiary hospital. Total Knowledge (TKS) and Total Side Effect Scores (TSES) were derived. Logistic regression analyses were employed to correlate socio-demographic factors with knowledge.
Results
Fifty-two participants were recruited, 20 at isoniazid commencement and 32 already on isoniazid. The average TKS were 5.04/9 and 6.23/9 respectively and were significantly associated with interpreter use. Approximately half did not know how tuberculosis was transmitted. The average TSES were 5.0/7 and 3.5/7 respectively, but were not influenced by socio-demographic factors.
Conclusions
There was suboptimal knowledge about LTBI. Improvements in health messages delivered via interpreters and additional methods of distributing information need to be developed for this patient population.